Hematoporphyrin Derivative

DBCAT001082Pharmacologic class

A complex mixture of monomeric and aggregated porphyrins used in the photodynamic therapy of tumors (HEMATOPORPHYRIN PHOTORADIATION). A purified component of this mixture is known as DIHEMATOPORPHYRIN ETHER. A DrugBank category of 2 drugs. 1 of them is approved.

Also known as: Hematoporphyrin D · Hematoporphyrin YHPD · Photofrin I · WR-246310 · YHPD, Hematoporphyrin
Drugs: Dihematoporphyrin ether
Porfimer sodium

What you can answer from here — as of August 24, 2016

2DrugsEach linked to its full drug card

Listed above

2Drug targetsEvery drug–target pair in the class, with bond type

6Marketed productsAcross the regions we cover, with dosage forms and routes

1Route of administrationHow the drugs in this class are given

Which targets do Hematoporphyrin Derivative share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account